0001209191-22-010718.txt : 20220217 0001209191-22-010718.hdr.sgml : 20220217 20220217161023 ACCESSION NUMBER: 0001209191-22-010718 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20220215 FILED AS OF DATE: 20220217 DATE AS OF CHANGE: 20220217 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Roth David CENTRAL INDEX KEY: 0001599014 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37813 FILM NUMBER: 22648152 MAIL ADDRESS: STREET 1: C/O SYROS PHARMACEUTICALS, INC. STREET 2: 620 MEMORIAL DRIVE CITY: CAMBRIDGE STATE: MA ZIP: 02139 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Syros Pharmaceuticals, Inc. CENTRAL INDEX KEY: 0001556263 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 453772460 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 35 CAMBRIDGE PARK DRIVE CITY: CAMBRIDGE STATE: MA ZIP: 02140 BUSINESS PHONE: 617-744-1340 MAIL ADDRESS: STREET 1: 35 CAMBRIDGE PARK DRIVE CITY: CAMBRIDGE STATE: MA ZIP: 02140 FORMER COMPANY: FORMER CONFORMED NAME: LS22, Inc. DATE OF NAME CHANGE: 20120815 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2022-02-15 0 0001556263 Syros Pharmaceuticals, Inc. SYRS 0001599014 Roth David C/O SYROS PHARMACEUTICALS, INC. 35 CAMBRIDGEPARK DRIVE CAMBRIDGE MA 02140 0 1 0 0 Chief Medical Officer Stock Option (right to buy) 1.59 2022-02-15 4 A 0 125000 0.00 A 2032-02-14 Common Stock 125000 125000 D Restricted Stock Units 2022-02-15 4 A 0 80000 0.00 A Common Stock 80000 80000 D Restricted Stock Units 2022-02-15 4 A 0 200000 0.00 A Common Stock 200000 200000 D This option becomes exercisable as to one quarter (1/4th) of the shares on February 28, 2023, with the remainder vesting in monthly installments equal to one forty-eighth (1/48th) of the original number of shares at the end of each of the next thirty-six (36) months thereafter. Each restricted stock unit ("RSU") represents the contingent right to receive one share of the issuer's common stock. These RSUs will vest in four equal annual installments commencing on March 31, 2023. These RSUs will vest in full on March 31, 2025. /s/ Gerald E. Quirk, as attorney-in-fact 2022-02-17